COMMUNIQUÉ DE PRESSE publié le 15/05/2023 à 09:00, il y a 3 années 2 mois Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases
COMMUNIQUÉ DE PRESSE publié le 10/05/2023 à 09:00, il y a 3 années 2 mois Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence in the German, Austrian and Swiss private equity markets
COMMUNIQUÉ DE PRESSE publié le 18/04/2023 à 09:15, il y a 3 années 3 mois Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics
COMMUNIQUÉ DE PRESSE publié le 13/04/2023 à 12:45, il y a 3 années 3 mois Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®
COMMUNIQUÉ DE PRESSE publié le 15/03/2023 à 13:05, il y a 3 années 4 mois Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure
COMMUNIQUÉ DE PRESSE publié le 16/02/2023 à 09:00, il y a 3 années 5 mois Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros
COMMUNIQUÉ DE PRESSE publié le 14/02/2023 à 09:00, il y a 3 années 5 mois Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million Nasdaq IPO
COMMUNIQUÉ DE PRESSE publié le 26/01/2023 à 13:10, il y a 3 années 5 mois Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches
COMMUNIQUÉ DE PRESSE publié le 10/01/2023 à 08:30, il y a 3 années 6 mois Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension
COMMUNIQUÉ DE PRESSE publié le 09/01/2023 à 14:00, il y a 3 années 6 mois Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group
Publié le 21/07/2026 à 17:05, il y a 2 heures 40 minutes Caldwell Appoints Steven Price Co-Leader of Life Sciences & Healthcare Practice
Publié le 21/07/2026 à 15:00, il y a 4 heures 45 minutes Four Nines Gold Begins Maiden Drill Program at Hayden Hill
Publié le 21/07/2026 à 15:00, il y a 4 heures 45 minutes BlackBerry SecuSUITE Secures Renewed NIAP Common Criteria Certification, Reinforcing Leadership in Sovereign Government-Grade Secure Communications
Publié le 21/07/2026 à 14:55, il y a 4 heures 50 minutes Vulcan Minerals Inc. - Drilling Completed at Carbonear Zinc-Lead SEDEX Project in Newfoundland
Publié le 21/07/2026 à 14:30, il y a 5 heures 15 minutes Sarama Completes Sale of its West Australian Gold Assets
Publié le 21/07/2026 à 18:50, il y a 54 minutes Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Publié le 21/07/2026 à 18:15, il y a 1 heure 29 minutes EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics
Publié le 21/07/2026 à 18:00, il y a 1 heure 44 minutes Hunyvers publie son chiffre d’affaires du troisième trimestre.
Publié le 21/07/2026 à 17:50, il y a 1 heure 54 minutes The New Measure of an EV Isn't Range, It's Peace of Mind
Publié le 21/07/2026 à 17:40, il y a 2 heures 4 minutes EQS-Adhoc: Airbus to present new mid-term outlook, strengthen commitment to profitable growth and shareholder returns during investor update
